White House AI Vetting Proposal Is Bad Policy

Why It Matters

A federal licensing scheme could curb startup entry and diminish the United States’ competitive edge in AI, while failing to address the inherent uncertainty of advanced models. Balancing safety with open innovation is essential for maintaining global leadership and economic growth.

Key Takeaways

• White House may require pre‑release AI safety approval
• Anthropic halted Mythos after internal cybersecurity risk findings
• Government vetting could favor incumbents, hinder startups
• Self‑policing and liability suits better align incentives
• Over‑regulation risks eroding US AI leadership

Pulse Analysis

The administration’s tentative shift toward an FDA‑style AI approval process reflects growing alarm over models like Anthropic’s Mythos, which demonstrated the ability to locate and exploit systemic cyber‑vulnerabilities. While the White House has long championed a hands‑off approach to foster rapid AI development, the Mythos episode has reignited calls for tighter oversight, echoing the European Union’s more prescriptive regulatory framework that has already slowed product rollouts and investment in the region.

However, applying a drug‑approval paradigm to generative AI overlooks a fundamental technical reality: AI behavior emerges from billions of interacting parameters, producing outcomes that are not fixed but highly context‑dependent. Unlike pharmaceuticals, where risks can be quantified and bounded, large language models operate in a space of "unknown unknowns," making reliable pre‑deployment safety certifications elusive. Persistent hallucinations and emergent capabilities further complicate risk modeling, suggesting that a government‑run vetting system would at best provide a false sense of security while imposing costly compliance burdens.

A more effective strategy leans on industry self‑regulation complemented by targeted liability mechanisms. Anthropic’s internal testing and its Project Glasswing partnership—granting limited access to Mythos for firms like Amazon and Google—illustrate how companies can proactively mitigate threats without waiting for bureaucratic clearance. Litigation that holds developers accountable for real‑world harms can also generate valuable data, shaping best‑practice standards organically. Preserving a flexible, competition‑driven ecosystem will help the United States retain its AI leadership while still addressing genuine safety concerns.